Cullinan Therapeutics Inc
(NAS:CGEM)
$
22.84
0.44 (1.96%)
Market Cap: 1.32 Bil
Enterprise Value: 861.16 Mil
PE Ratio: 0
PB Ratio: 2.31
GF Score: 36/100 Cullinan Oncology Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 04:30PM GMT
Release Date Price:
$28.89
(+0.49%)
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
Welcome to the Morgan Stanley Global Healthcare Conference. I'm Jeff Hung, one of the biotech analysts. For important closures please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. (Operator Instructions). CEO, Owen Hughes; and CFO, Jeff Trigilio, welcome.
Owen P. Hughes
Cullinan Oncology, Inc. - CEO, President & Director
Thank you.
Jeffrey Trigilio
Cullinan Oncology, Inc. - CFO & Treasurer
Thank you.
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
For those who may not be familiar with Cullinan, can you provide a brief introduction?
Owen P. Hughes
Cullinan Oncology, Inc. - CEO, President & Director
Sure. Jeff, thank you very much for the introduction and happy to participate in the conference. So
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot